Scholar Rock Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Scholar Rock Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013530
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Scholar Rock Inc (Scholar Rock), a subsidiary of Scholar Rock LLC is a biotechnology company that discovers and develops biologic therapies. It develops niche activators, modulating supracellular activation, for the application in the treatment of diseases such as fibrosis, diseases of musculoskeletal systems, and autoimmune diseases, using its proprietary technology. Scholar Rock’s proprietary platform enables to create a new class of biologic therapeutics. Its research and development activities concentrate on identifying niche activators. Scholar Rock’s product pipeline focuses in the therapeutic areas of muscle disease, fibrosis, autoimmunity and immuno-oncology. The company’s proprietary technology platform also enables to discover and optimize drug candidates. It collaborates with various biotechnology companies. Scholar Rock is headquartered in Cambridge, Massachusetts, the US.

Scholar Rock Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Scholar Rock Raises USD36 Million in Series B Financing 10
Scholar Rock Raises USD20 Million in Series A Venture Financing 12
Partnerships 13
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 13
Licensing Agreements 14
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 14
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 15
Scholar Rock Inc – Key Competitors 16
Scholar Rock Inc – Key Employees 17
Scholar Rock Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jul 06, 2017: Scholar Rock Appoints David L. Hallal as Chairman of Board of Directors 19
May 23, 2017: Scholar Rock Announces Drug Development Leaders, Michael Gilman and Shelia Violette, to Join Scientific Advisory Board 20
Nov 22, 2016: Scholar Rock Strengthens R&D Leadership with Appointments of New Board Member and Chief Scientific Officer 22
Mar 08, 2016: Scholar Rock Appoints Yung Chyung, MD, as Chief Medical Officer 23
Jan 04, 2016: Scholar Rock Announces Appointment of Leading Fibrosis Expert Dr. Scott L. Friedman to Scientific Advisory Board 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Scholar Rock Inc, Pharmaceuticals & Healthcare, Key Facts 2
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Scholar Rock Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Scholar Rock Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Scholar Rock Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Scholar Rock Raises USD36 Million in Series B Financing 10
Scholar Rock Raises USD20 Million in Series A Venture Financing 12
Scholar Rock Enters Into Research Collaboration With Johnson & Johnson Innovation And Janssen Biotech 13
Janssen Biotech Exercises Option for Licensing Agreement with Scholar Rock 14
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 15
Scholar Rock Inc, Key Competitors 16
Scholar Rock Inc, Key Employees 17

★海外企業調査レポート[Scholar Rock Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Devon Energy Corporation:企業の戦略・SWOT・財務情報
    Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Showa Shell Sekiyu KK (5002):企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Laboratorios Farmaceuticos Rovi SA (ROVI):企業の財務・戦略的SWOT分析
    Summary Laboratorios Farmaceuticos Rovi SA (Rovi) is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of prescription and hospital products. The company's product portfolio includes licensed prescription pharmaceuticals in the therapeutic areas of cardiovas …
  • Olympic Mountain and Marine Products, Inc.:企業の戦略・SWOT・財務情報
    Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Royale Energy Inc (ROYL):企業の財務・戦略的SWOT分析
    Summary Royale Energy Inc (Royale Energy) is an independent exploration and production company. The company undertakes the business of acquisition, development, and marketing of oil and natural gas properties. Its business activities comprise acquisition of oil and gas interests and proved reserves, …
  • ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy and other bio products. It provides vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s v …
  • EDP – Energias do Brasil SA:企業の戦略・SWOT・財務情報
    EDP - Energias do Brasil SA - Strategy, SWOT and Corporate Finance Report Summary EDP - Energias do Brasil SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oil States International Inc (OIS):企業の財務・戦略的SWOT分析
    Oil States International Inc (OIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Genenta Science srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Genenta Science srl (Geneta Science) is a biotechnology company that develops gene therapies based on transcriptional and mirRNA-mediated controls. The company develops gene transfer strategy into autologous hematopoietic stem and progenitor cells in order to target interferon-a expression t …
  • Navigant Consulting Inc (NCI):企業の財務・戦略的SWOT分析
    Summary Navigant Consulting Inc (Navigant Consulting) is a consultancy service provider that provides integrated solutions to assist companies and legal counsel in improving stakeholder value and operations. The company offers growth strategy, operations and transaction advisory services such as str …
  • EMS SA:製薬・医療:M&Aディール及び事業提携情報
    Summary EMS SA (EMS) is a pharmaceutical company, which is focused in the development of products for improvement of health and well-being of the population. It operates in prescription segments generics, branded pharmaceuticals, OTC and hospital. It has presence in the US market through Brace Pharm …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • DormaKaba Holding AG:企業の戦略・SWOT・財務情報
    DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report Summary DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Dominion Energy Inc.:企業の戦略・SWOT・財務分析
    Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Jim Pattison Group:企業の戦略・SWOT・財務情報
    The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report Summary The Jim Pattison Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):製薬・医療:M&Aディール及び事業提携情報
    Summary China Resources Sanjiu Medical & Pharmaceutical Co Ltd (Sanjiu) a subsidiary of China Resources (Holdings) Co., Ltd. researches and develops, manufactures and commercializes pharmaceutical products including traditional Chinese medicine OTC and prescription drugs. Sanjiu’s product portfolio …
  • Novanta Inc (NOVT):企業の財務・戦略的SWOT分析
    Novanta Inc (NOVT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The National Commercial Bank:企業の戦略・SWOT・財務情報
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Neuronetics Inc (STIM):医療機器:M&Aディール及び事業提携情報
    Summary Neuronetics Inc (Neuronetics) is a medical device company that develops non-invasive therapies for psychiatric and neurological disorders. The company provides neurostar TMS therapy system used to treat patients with depressive disorder. Its neurostar TMS components comprise practice data ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆